Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Integral Health Asset Management, LLC
Form 13F · Q2 2026

Integral Health Asset Management, LLC

CIK 1773206申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$25.3亿
申报组合市值
92
持仓数量
12
Quarters on record
Top 50
持仓数量

Integral Health Asset Management, LLC——持仓

共 92 个持仓中的前 50 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1RVMD Revolution Medicines Inc1.5M+0.0%$2.8亿11.1%
2INSM Insmed Inc1.6M+6.7%$1.7亿6.7%
3CYTK Cytokinetics Inc1.6M+0.0%$1.4亿5.4%
4CVS Cvs Health Corp1.1M+633.3%$1.1亿4.5%
5EWTX Edgewise Therapeutics Inc2.0M+25.0%$8126万3.2%
6VERA Vera Therapeutics Inc1.8M+9.4%$7509万3.0%
7AXSM Axsome Therapeutics Inc.300,000+757.1%$7343万2.9%
8CAH Cardinal Health Inc300,000+11.1%$7127万2.8%
9ROIV Roivant Sciences Ltd2.0M+0.0%$7078万2.8%
10RYTM Rhythm Pharmaceuticals Inc550,000−8.3%$6107万2.4%
11EW Edwards Lifesciences Corp625,000+267.6%$5654万2.2%
12ALHC Alignment Healthcare Inc2.0M−22.3%$4762万1.9%
13MRK Merck & Co Inc350,000−17.6%$4498万1.8%
14DGX Quest Diagnostics Inc200,000+233.3%$4239万1.7%
15QURE Uniqure Nv900,000+0.0%$4145万1.6%
16SRRK Scholar Rock Hldg Corp750,000+50.0%$4125万1.6%
17BSX Boston Scientific Corp900,000+63.6%$3841万1.5%
18BTSG Brightspring Health Svcs Inc550,000−56.0%$3836万1.5%
19ABT Abbott Laboratories400,000—$3630万1.4%
20UNH Unitedhealth Group Inc85,000—$3533万1.4%
21LFST Lifestance Health Group Inc3.0M−30.2%$3213万1.3%
22NVS Novartis Ag200,000−20.0%$3134万1.2%
23TNGX Tango Therapeutics Inc1.0M+122.2%$3126万1.2%
24THC Tenet Healthcare Corp165,000—$3087万1.2%
25SYRE Spyre Therapeutics Inc325,000—$2885万1.1%
26NVO Novo-Nordisk A S600,000—$2876万1.1%
27DFTX Definium Therapeutics Inc550,000+37.5%$2587万1.0%
28NBIX Neurocrine Biosciences Inc150,000+0.0%$2528万1.0%
29REGN Regeneron Pharmaceuticals40,000−52.9%$2494万1.0%
30BIIB Biogen Inc100,000+66.7%$2161万0.9%
31TVTX Travere Therapeutics Inc375,000—$2130万0.8%
32LNTH Lantheus Hldgs Inc190,000+52.0%$2108万0.8%
33GKOS Glaukos Corp150,000−14.3%$2096万0.8%
34ORIC Oric Pharmaceuticals Inc1.9M+35.7%$2058万0.8%
35BBIO Bridgebio Pharma Inc275,000+0.0%$2048万0.8%
36VRTX Vertex Pharmaceuticals Inc40,000+0.0%$1987万0.8%
37ALMS Alumis Inc700,000−12.5%$1970万0.8%
38ELV Elevance Health Inc Formerly50,000−33.3%$1934万0.8%
39CNC Centene Corp Del300,000−53.8%$1926万0.8%
40ERAS Erasca Inc1.0M+42.9%$1832万0.7%
41LLY Eli Lilly & Co15,000+0.0%$1799万0.7%
42ARWR Arrowhead Pharmaceuticals In200,000−33.3%$1630万0.6%
43NVST Envista Holdings Corporation600,000+71.4%$1581万0.6%
44MDT Medtronic Plc200,000—$1565万0.6%
45WAT Waters Corp40,000—$1500万0.6%
46LIVN Livanova Plc180,000+20.0%$1480万0.6%
47FORTE BIOSCIENCES INC Forte Biosciences Inc675,000+350.0%$1434万0.6%
48MDGL Madrigal Pharmaceuticals Inc25,000+0.0%$1342万0.5%
49PRAX Praxis Precision Medicines I40,000+0.0%$1339万0.5%
50ANRO Alto Neuroscience Inc500,000+0.0%$1320万0.5%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。